Pharma-Bio Serv (PBSV) Change in Accured Expenses (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Change in Accured Expenses came in at -$546515.0 in Q2 2026, up 8.58% YoY from -$503312.2 in Q2 2025, and down 269.13% on a QoQ basis from -$148056.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has 17 years of Change in Accured Expenses data on file, last reported at -$546515.0 in Q2 2026.
- Quarterly Change in Accured Expenses rose 8.58% year-over-year to -$546515.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$736605.0 (up 39.15% YoY) and the FY2025 annual result came in at -$853006.0, up 29.35% from the prior year.
- Change in Accured Expenses fell to -$546515.0 in Q2 2026, from -$148056.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $170854.0 in Q3 2023 to a low of -$597831.0 in Q2 2025.
- A 5-year average of -$212887.1 and a median of -$200893.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 305.27% — and 2024, when it slumped 1618.45%.
- Tracing PBSV's Change in Accured Expenses over 5 years: stood at -$83385.0 in 2022, then tumbled by 285.47% to -$321427.0 in 2023, then jumped by 83.03% to -$54545.0 in 2024, then soared by 245.93% to $79597.0 in 2025, then sank by 786.6% to -$546515.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$546515.0 (Q2 2026), -$148056.0 (Q1 2026), and $79597.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 8.92 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 16.92 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | -873,000.00 |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 3.12 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | -28.48 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 67.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 20.21 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | -2.43 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | -546,515.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -546,515.00 |
| Apr 30, 2026 | -546,515.00 |
| Jan 31, 2026 | -148,056.00 |
| Jan 31, 2026 | -148,056.00 |
| Oct 31, 2025 | 79,597.00 |
| Oct 31, 2025 | 79,597.00 |
| Jul 31, 2025 | -121,631.00 |
| Jul 31, 2025 | -121,631.00 |
| Apr 30, 2025 | -597,831.00 |
| Apr 30, 2025 | -597,831.00 |
| Jan 31, 2025 | -213,141.00 |
| Jan 31, 2025 | -213,141.00 |
| Oct 31, 2024 | -54,545.00 |
| Oct 31, 2024 | -54,545.00 |
| Jul 31, 2024 | -345,041.00 |
| Jul 31, 2024 | -345,041.00 |
| Apr 30, 2024 | -376,637.00 |
| Apr 30, 2024 | -376,637.00 |
| Jan 31, 2024 | -431,106.00 |
| Jan 31, 2024 | -431,106.00 |